Biomarin Pharmaceutical Inc (BMRN)
66.63
+0.36
(+0.54%)
USD |
NASDAQ |
Dec 24, 16:00
Biomarin Pharmaceutical Free Cash Flow: 300.88M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co Inc | 14.84B |
| Biogen Inc | 1.768B |
| Pfizer Inc | 8.227B |
| Bristol-Myers Squibb Co | 13.80B |
| Moderna Inc | -3.956B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 221.48M |
| Cash from Investing (Quarterly) | -16.16M |
| Cash from Financing (Quarterly) | -499.12M |
| Free Cash Flow Per Share (Quarterly) | 1.016 |
| Free Cash Flow to Equity (Quarterly) | 694.63M |
| Free Cash Flow to Firm (Quarterly) | 200.30M |
| Free Cash Flow Yield | 2.30% |